{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:36:23Z","timestamp":1787510183083,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"De Hingh reports an unrestricted research grant from RanD\/QPS and Roche, outside the submitted work, paid to the institute."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity is a major global health problem and an important risk factor for colorectal cancer (CRC) is increased body weight. Obesity plays a role in the peritoneal dissemination of cancer; however, it is unclear whether this also applies for peritoneal dissemination of CRC. The purpose of this study was to provide insight in the role of obesity on the peritoneal dissemination of colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Of all patients diagnosed with CRC in the Netherlands in the first half of 2015, follow-up data was completed in 2019. Weight at time of primary diagnosis was categorized as underweight, normal weight, overweight, or obese. Logistic regression modelling was used to assess the association between weight and the presence of synchronous colorectal peritoneal metastases (CPM), and Cox regression modelling was used to assess the association between weight and metachronous CPM. Patient and tumor characteristics were taken into account. The analyses were adjusted for tumor stage, nodal stage, tumor location, and tumor histology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 6436 patients were included in this study. Two-hundred ninety-three (4.6%) patients presented with synchronous CPM at the time of primary diagnosis, while another 278 (5.1%) patients developed metachronous CPM after a median time of 16.5\u00a0months. Univariable and multivariable logistic regression modelling did not identify an effect of weight on the presence of synchronous CPM. Neither underweight (odds ratio [OR] 1.10, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.48\u20132.54), nor overweight (\n                      <jats:italic>OR<\/jats:italic>\n                      0.96, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.71\u20131.29), or obesity (\n                      <jats:italic>OR<\/jats:italic>\n                      0.84, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.56\u20131.26) was either positively or negatively associated with the presence of synchronous peritoneal metastases as compared to normal weight. Univariable and multivariable Cox regression modelling did not identify an effect of weight on the development of metachronous CPM. Neither underweight (\n                      <jats:italic>HR<\/jats:italic>\n                      0.162, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.02\u20131.16), nor overweight (\n                      <jats:italic>HR<\/jats:italic>\n                      1.07, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.82\u20131.39), or obesity (\n                      <jats:italic>HR<\/jats:italic>\n                      1.02, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.73\u20131.16) was either positively or negatively associated with the presence of synchronous peritoneal metastases as compared to normal weight.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CRC patients who are overweight or obese are not more at risk for the presence of synchronous CPM nor development of metachronous CPM than their normal-weight counterparts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-03204-5","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:02:40Z","timestamp":1697425360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Vincent C. J.","family":"van de Vlasakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Lurvink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W.","family":"Nienhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"3204_CR1","volume-title":"Obesity and overweight","author":"Organization WWH","year":"2021","unstructured":"Organization WWH. Obesity and overweight. 2021. 31\u201310\u20132022."},{"key":"3204_CR2","volume-title":"Cijfers Darmkanker","author":"Nederland IIK","year":"2022","unstructured":"Nederland IIK. Cijfers Darmkanker. 2022. 31\u201310\u20132022."},{"issue":"5","key":"3204_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","volume":"47","author":"RJ Lurvink","year":"2021","unstructured":"Lurvink RJ, Bakkers C, Rijken A, van Erning FN, Nienhuijs SW, Burger JW, et al. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. Eur J Surg Oncol. 2021;47(5):1026\u201333.","journal-title":"Eur J Surg Oncol"},{"issue":"6 Suppl C","key":"3204_CR4","first-page":"S5","volume":"13","author":"AB Benson 3rd","year":"2007","unstructured":"Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007;13(6 Suppl C):S5-18.","journal-title":"J Manag Care Pharm"},{"issue":"9","key":"3204_CR5","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s10620-008-0410-z","volume":"53","author":"P Moayyedi","year":"2008","unstructured":"Moayyedi P. The epidemiology of obesity and gastrointestinal and other diseases: an overview. Dig Dis Sci. 2008;53(9):2293\u20139.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"3204_CR6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer\u2014viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794\u20138.","journal-title":"N Engl J Med"},{"key":"3204_CR7","doi-asserted-by":"crossref","unstructured":"Barone I, Giordano C, Bonofiglio D, Ando S, Catalano S. The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives. In Seminars in cancer biology.\u00a0Academic Press. 2020;60:274\u201384.","DOI":"10.1016\/j.semcancer.2019.09.001"},{"issue":"11","key":"3204_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498\u2013503.","journal-title":"Nat Med"},{"issue":"12","key":"3204_CR9","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.3390\/cancers12123798","volume":"12","author":"S Annett","year":"2020","unstructured":"Annett S, Moore G, Robson T. Obesity and cancer metastasis: molecular and translational perspectives. Cancers (Basel). 2020;12(12):3798.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"3204_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","volume":"62","author":"M Bardou","year":"2013","unstructured":"Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62(6):933\u201347.","journal-title":"Gut"},{"issue":"5","key":"3204_CR11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.2353\/ajpath.2006.051222","volume":"169","author":"SA Gerber","year":"2006","unstructured":"Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol. 2006;169(5):1739\u201352.","journal-title":"Am J Pathol"},{"key":"3204_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2017.10.020","volume":"48","author":"A Vecchi\u00e9","year":"2018","unstructured":"Vecchi\u00e9 A, Dallegri F, Carbone F, Bonaventura A, Liberale L, Portincasa P, et al. Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Intern Med. 2018;48:6\u201317.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"3204_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5009\/gnl20266","volume":"16","author":"JW Park","year":"2022","unstructured":"Park JW, Chang SY, Lim JS, Park SJ, Park JJ, Cheon JH, et al. Impact of visceral fat on survival and metastasis of stage III colorectal cancer. Gut Liver. 2022;16(1):53\u201361.","journal-title":"Gut Liver"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03204-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03204-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03204-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:33:00Z","timestamp":1700544780000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03204-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03204-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the nationwide and anonymous nature of the data, no medical ethical approval was required for this study. The study was conducted in accordance with the Declaration of Helsinki and was approved by the scientific research board of the Netherlands Cancer Registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"De Hingh reports an unrestricted research grant from RanD\/QPS and Roche, outside the submitted work, paid to the institute.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}